期刊
TRENDS IN CARDIOVASCULAR MEDICINE
卷 19, 期 5, 页码 173-177出版社
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tcm.2009.10.003
关键词
-
资金
- NHLBI NIH HHS [U01 HL069757, U01 HL069757-09] Funding Source: Medline
Statins, or 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) inhibitors, are widely prescribed to lower plasma cholesterol levels and reduce cardiovascular disease risk. Despite the well-documented efficacy of statins, there is large interindividual variation in response. Using a panel of immortalized lymphocyte cell lines incubated with simvastatin, we recently found that the magnitude of expression of an alternatively spliced HMGCR transcript lacking exon 13 was inversely correlated with in vivo reductions of total cholesterol, low-density lipoprotein cholesterol, apoB, and triglycerides after statin treatment of the individuals from whom the cells were derived. This review will discuss the potential significance of alternative splicing as a mechanism contributing to variation in statin efficacy as well as the use of immortalized lymphocyte cell lines for identifying pharmacogenetically relevant polymorphisms and molecular mechanisms. (Trends Cardiovasc Med 2009;19:173-177) (C) 2009, Elsevier Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据